Board of Directors

Richard C. Carlson

CEO and Director since 2006 and Acting Chairman of the Board

Rick has extensive experience in bringing new medical products to market during his more than 34 years in the medical industry. He has served in a broad range of operating roles including positions in marketing, sales, international and strategic planning with Companies marketing urology, orthopedic, cardiology, ophthalmology and neurology products. Most recently, he was with SurModics, Inc. where he was Vice President of Marketing/Sales and Strategic Planning. Prior to that he provided marketing support for one of Boston Scientific’s specialty businesses in Europe. Mr. Carlson has held senior management positions at C. R. Bard, Advanced Surgical Intervention, Medtronic and American Medical Systems. Mr. Carlson has a BS in Business Economics and MBA in Marketing from the University of Minnesota.

Outside Directors:

Michael Chambers, JD, Ph.D.

Director since 2010

Dr. Chambers is an experienced attorney, angel investor and entrepreneur. Dr. Chambers currently serves as President and CEO of Swift Biotechnology, a company he recently co-founded. Swift is pursuing development of screening technologies, developed by the Mitchell Cancer Institute,for gynecological cancers. Prior to Swift, he helped found InnoRx Pharmaceuticals in 1999, a privately held company that specialized in the development of drugs and drug delivery systems for ocular disease. He served as President and CEO of InnoRx until negotiating its sale to SurModics in 2005. At InnoRx he managed development of multiple pipeline technologies and licensing opportunities in the US and world-wide. He speaks fluent French and Spanish. In addition to his law degree, he was awarded a doctorate from the University of Geneva in Switzerland where he was a Swiss Confederation Fellow, and previously studied in France as a Rotary Ambassadorial Scholar. He is "Of Counsel" to the law firm of Cabaniss Johnston and frequently advises companies and academic institutions on growth, financing and licensing opportunities related to new technologies. Dr. Chambers is a member of the Governance and Nominating Committee.

James Davis

Director since 2010

Mr. Davis is an active investor in ProUroCare and other entrepreneurial companies throughout the U.S. He has considerable experience developing and implementing business and financing strategies for early stage growth companies. He also has previous board experience and has participated in compensation reviews and policy development. Mr. Davis is President of Davis & Associates, Inc., a company he founded more than 30 years ago that represents the leading edge lighting and controls manufacturers throughout the upper Midwest. Mr. Davis was a founding Board Member of Arcadia Financial, LTD, which before its sale to CitiFinancial became the nation's largest independent provider of automobile financing after raising more than $315 million in debt and equity financing. Mr. Davis is a member of the Compensation Committee.

David F. Koenig

Director since 2004

Mr. Koenig served as a director of our predecessor company, ProUroCare, Inc. (“PUC”), from 1999 until April 2004, when he became a director of the Company upon its merger with PUC. From 1996 to 2005, Mr. Koenig was the Executive Vice President and Chief Operating Officer of Solar Plastics, Inc., a manufacturer of custom rotationally molded plastic parts, and currently consults with various companies on the development of strategic plans. Mr. Koenig is Chairman of the Compensation Committee.

Lawrence W. Getlin, JD

Director since June 2011

Mr. Getlin served as Senior Vice President of Corporate Compliance, Legal and Quality at American Medical Systems from June of 2006 to April of 2010, and previously as its Vice President of Regulatory, Clinical Affairs and Quality Systems for 15 years. Before joining American Medical Systems he directed U.S. and international regulatory approval programs and GMP compliance initiatives at the Pharmaseal Division of Baxter Healthcare for over 14 years. Mr. Getlin has contributed to the revised and restated AdvaMed Code of Ethics on Interactions with Health Care Professionals. He is currently a member of the St. Cloud State University Regulatory Affairs and Services and Applied Clinical Research Master of Science Industry Advisory Board. He is a member of the California State Bar Association, American Bar Association, Health Law Section and the Regulatory Affairs Professional Society (RAPS). Mr. Getlin is a member of the Governance and Nominating Committee.

Robert J. Rudelius

Director since 2007

Since 2003, Mr. Rudelius has been the Managing Director and CEO of Noble Ventures, LLC, a company he founded, providing advising and consulting services to early-stage companies in the information technology, renewable energy and loyalty marketing fields. Mr. Rudelius is currently a member of the board of directors of Axogen Corporation. Axogen has created and licensed a unique combination of patented technologies that provide surgeons with solutions to repair and protect patients' peripheral nerve injuries. Mr. Rudelius is the Chairman of the Governance and Nominating Committee and is a member of the Audit Committee.

Scott E. Smith

Director since 2006

Mr. Smith currently serves as the Managing Director for Adams Harris, a consulting & professional services firm specializing in the areas of internal audit, accounting and finance, corporate tax, and technology process and controls; providing consulting, co-sourcing, out-sourcing, and project management solutions. He was previously employed by F-2 Intelligence Group (“F2”), a company engaged in providing critical insights to multinational corporations and private equity clients on a broad range of strategic issues. From 2004 to 2008, Mr. Smith served as F2’s Regional Director of Sales for Private Equity, where he advised private equity firms on market and competitive intelligence issues. Prior to joining F2, Mr. Smith was employed by Arthur Andersen for 23 years and served the last 10 years as an audit partner. Mr. Smith is a Certified Public Accountant and a Certified Management Accountant. Mr. Smith is Chairman of the Audit Committee and a member of the Compensation Committee.